首页> 外文OA文献 >Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial

【2h】

Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial

机译：中剂量美法仑与多发性骨髓瘤清髓性治疗的比较：荷兰合作组织HOVON 24试验的长期随访

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Sonneveld, Pieter; van der Holt, Bronno; Segeren, Christine M.; Vellenga, Edo; Croockewit, Alexandra J.; Verhoe, Gregor E. G.; Cornelissen, Jan J.; Schaafsma, Martijn R.; van Oers, Marinus H. J.; Wijermans, Pierre W.; Westveer, Petra H. M.; Lokhorst, Henk M.;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial | Haematologica [J] . Pieter Sonneveld, Bronno van der Holt, Christine M. Segeren, Haematologica . 2007,第7期

机译：中剂量美法仑与多发性骨髓瘤清髓性治疗的比较：荷兰合作组织HOVON 24试验的长期随访|血液学
2. Geriatric Impairments and Low Muscle Mass Are Associated with Treatment Discontinuation and Overall Survival in Newly Diagnosed Non-Transplant Eligible Multiple Myeloma Patients (nte-NDMM) Treated with Dose-Adjusted Melphalan-Prednisone-Bortezomib (MPV) - Results of the Dutch HOVON 123 Study [J] . Stege Claudia A. M., Nasserinejad Kazem, Levin Mark-David, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：Geriatric损伤和低肌肉质量与治疗中断和整体生存有关，在新诊断的非移植符合的多发性骨髓瘤患者（NTE-NDMM）用剂量调整后的Melphalan-Prednisone-Bortezomib（MPV） - 荷兰霍肯123研究的结果
3. Bortezomib plus melphalan and prednisone compared with melphalan and prednisone in previously untreated multiple myeloma: updated follow-up and impact of subsequent therapy in the phase III VISTA trial. [J] . Mateos MV, Richardson PG, Schlag R, Journal of Clinical Oncology . 2010,第13期

机译：在先前未治疗的多发性骨髓瘤中，硼替佐米加美法仑和泼尼松与美法仑和泼尼松比较：VISTAⅢ期临床试验的最新随访和后续治疗的影响。
4. Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine doxorubicin dexamethasone induction in amyloid light chain amyloidosis of the prospective phase II HOVON-41 study by the Dutch-Belgian Co-operative Trial Group for Hematology Oncology [O] . Bouke P.C. Hazenberg, Alexandra Croockewit, Bronno van der Holt, 2015

机译：荷兰-比利时血液学合作研究小组前瞻性II期HOVON-41研究中长春新碱阿霉素地塞米松诱导淀粉样蛋白轻链淀粉样变性后大剂量美法仑和自体干细胞移植的扩展随访
5. Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma : long-term follow-up of the Dutch Cooperative Group HOVON 24 trial [O] . Sonneveld P., Holt B. van der, Segeren C.M., 2007

机译：中剂量美法仑与多发性骨髓瘤清髓性治疗的比较：荷兰合作组织HOVON 24试验的长期随访

Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial

著录项

相似文献

相关主题

期刊订阅